P2/3 starting soon, confidence in ODD, and strong P1 data, Relyvrio being pulled and a less superior sale anchor at $2.4B
We should only be wanting the price to increase if you have finished buying.
Im happy for it to sit low right now while I accumulate. You don't get many short term chances like this while the market is asleep.
Very different biotech here than hoping your cancer drug in a saturated market, with side effects, and 500+ other trials is going to make it through.
Don't waste this opportunity.
P2/3 starting soon, confidence in ODD, and strong P1 data,...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.90M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 25000 | 1 |
View Market Depth
| Last trade - 16.12pm 08/05/2024 (20 minute delay) ? |
| PAA (ASX) Chart |
Day chart unavailable